Joan Fusco, PhD
Chief Operating Officer
Dr. Joan Fusco has thirty years’ experience in the biotechnology/vaccines industry serving across major functional areas with 20 of those years in executive management holding responsibility for technical, programmatic and general operations. Her expertise is navigating the biopharmaceutical product development life cycle from concept to commercialization. Her various operational leadership positions have resulted in the successful commercialization of four new products with significant healthcare and revenue impact (2 US and 2 EU/Can/Global).
Dr. Fusco earned her Ph.D. in Microbiology (Biological Sciences; bacterial virulence/immunity factors) from the University of Pittsburgh. She has deep experience in the development of a multitude of vaccine products for existing and emerging infectious diseases and biothreats, including filoviruses, meningitis A/B/C, Hib, Group B strep, Group A strep, pseudomonas, gonorrhea, diphtheria, tetanus, pertussis, polio, pneumococcus, West Nile, Japanese encephalitis, smallpox, anthrax, plague, influenza (seasonal and pandemic), and Zika. She has presented at numerous conferences and most recently served on Wellcome Trust’s Ebola Vaccine Team B.
Chief Business Officer
Michael McGinnis has over twenty years of general management, international business development, strategic planning, alliance management, marketing and program management experience in the Pharmaceutical and Biotechnology industries. He has executive-level industry experience, with particular competencies around progressing product development programs and driving the achievement of organizational growth targets.
Mr. McGinnis earned a B.S. in Business Administration from Towson University, an M.B.A. from Loyola University Maryland, and an M.S. in Biotechnology from Johns Hopkins University.